Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
This grant aims to support research focused on understanding how incretin mimetics (drugs affecting hormones like GLP-1 and GIP-1) influence cancer risk, rather than their short-term effects like weight loss or diabetes. The goal is to attract knowledgeable scientists to explore the mechanisms by which these agents may increase the risk of certain cancers while decreasing the risk of others as…
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientist…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers